EMBR LABS ANNOUNCES PUBLICATION OF GROUNDBREAKING STUDY ON HOT FLASHES IN PROSTATE CANCER PATIENTS IN PRESTIGIOUS NATURE JOURNAL
21 Dec 2023
BOSTON, Dec. 21, 2023 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading temperature wearable, today announced the publication of "Feasibility of a Novel Wearable Thermal Device for Management of Bothersome Hot Flashes in Patients with Prostate Cancer" in Nature Journal's Prostate Cancer and Prostatic Diseases.
Continue Reading
"Novel technology truly moves the field forward in improving the quality of life for men with prostate cancer."
Post this
Preview
Source: PRNewswire
Embr Labs for Men
A first of its kind study, Embr labs collaborated with the Dana-Farber Cancer InstituteCancer Institute in groundbreaking research in which men with prostate cancer found the Embr Wave device effective at managing hot flashes brought on by cancer treatment. This is the first study to evaluate the feasibility of a wearable thermal device for nonmedicinal management of impactful hot flashes in prostate cancer patients. Because hot flashes are associated with significantly reduced quality of life, including sleep impairment, hot flash management in affected individuals is a critical component of prostate cancer survivorship.
"During treatment for prostate cancer, there are many complications we consider when we think about how to optimize survivorship," said Dr. Alicia Morgans, Medical Director of the Survivorship Program at Dana-Farber Cancer InstituteCancer Institute. "This study, using a novel technology to manage hot flashes, truly moves the field forward in improving the quality of life for men with prostate cancer."
"For years, men suffering from hot flashes had limited and ineffective options, including the use of fans, dressing in layers or taking medications associated with side effects," added Dr. Pam Peeke, lead author and Senior Clinical Investigator for Embr Labs. "This pivotal study demonstrates that the use of a thermal device could provide a nonpharmacological management option for bothersome hot flashes."
"Living well during prostate cancer treatment through survivorship science is a key goal for our organization in its mission to reduce the death and suffering from this disease," said Prostate Cancer Foundation CEO Charles J. Ryan, MD. "This study provides evidence that control of irritating hot flashes is possible, and patients can consider this approach for maintaining quality of life during hormonal therapy."
The study follows Embr's announcement of its new technology to predict a menopausal hot flash before it occurs to activate immediate cooling on the Embr Wave to mitigate or alleviate the hot flashes.
About Embr Labs, Inc.
Embr Labs is the leading healthtech company addressing health conditions through the use of temperature. The company's technology delivers a new category of natural solutions to manage hot flashes, sleep issues, stress, and thermal discomfort. The company was founded at MIT and is backed by Bose Ventures, DigiTx Partners, Safar Partners, Esplanade Ventures, and Ghost Tree Partners. Embr Labs has won numerous awards, including the AARP Innovation in Aging Award, Time Magazine's Best Inventions, the iF Design Award and was named to CB Insights' Digital Health 150.
CONTACT: Sam Shames: sam@embrlabs.com
SOURCE Embr Labs
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.